Conditions and Indications A–Z
Browse an A–Z index of health conditions and treatment indications linked to medicines available through Medic Force in the UAE and Middle East.
Major Depressive DisorderMajor Depressive Disorder is a medical condition that can affect daily quality of life. The medicines listed here belong to treatment classes that may be prescribed as part of a broader care plan.24 medicinesView Major Depressive DisorderMajor Depressive Disorder AdjunctMajor Depressive Disorder Adjunct involves changes in health that require professional assessment and long term management. The pharmaceutical options shown here include medicine groups that form part of the available therapeutic strategies.1 medicineView Major Depressive Disorder AdjunctMalariaMalaria is a health condition that may require pharmaceutical intervention. Products containing Chloroquine are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView MalariaMalaria ProphylaxisMalaria Prophylaxis is a health condition that can affect people of various ages. Medicines such as Doxycycline, Hydroxychloroquine, Mefloquine and related treatments are commonly included in care plans to address the underlying causes or provide symptomatic improvement.3 medicinesView Malaria ProphylaxisMalaria Radical CureMalaria Radical Cure can affect wellbeing and daily functioning. The medicine types shown here, including Primaquine, represent treatment options that may be considered for managing this condition effectively.1 medicineView Malaria Radical CureMale HypogonadismMale Hypogonadism describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Testosterone, Mesterolone and similar medicines, which work through different mechanisms to manage the condition or its effects.2 medicinesView Male HypogonadismMalignant LymphomasMalignant Lymphomas is a health condition that may require pharmaceutical intervention. Products containing Cyclophosphamide are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView Malignant LymphomasManic EpisodesPeople living with Manic Episodes face a complex health challenge. The treatments covered on this page represent medicine types that clinicians may consider as part of individualised management.1 medicineView Manic EpisodesMantle Cell Lymphoma in Adult Patients Who Have Received At Least One Prior TherapyMantle Cell Lymphoma in Adult Patients Who Have Received At Least One Prior Therapy is a recognised clinical indication. The medicines listed below cover treatment groups that may be part of a clinical care plan. Product details are provided for comparison.1 medicineView Mantle Cell Lymphoma in Adult Patients Who Have Received At Least One Prior TherapyMantle Cell Lymphoma in Adult Patients with Previously Untreated Disease in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone Followed by Ibrutinib MonotherapyMantle Cell Lymphoma in Adult Patients with Previously Untreated Disease in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone Followed by Ibrutinib Monotherapy is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Mantle Cell Lymphoma in Adult Patients with Previously Untreated Disease in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone Followed by Ibrutinib MonotherapyMantle Cell Lymphoma in Adult Patients with Relapsed or Refractory DiseasePeople living with Mantle Cell Lymphoma in Adult Patients with Relapsed or Refractory Disease face a complex health challenge. The treatments covered on this page represent medicine types that clinicians may consider as part of individualised management.1 medicineView Mantle Cell Lymphoma in Adult Patients with Relapsed or Refractory DiseaseMarginal Zone Lymphoma in Combination with Rituximab in Adult Patients with Previously Treated DiseaseMarginal Zone Lymphoma in Combination with Rituximab in Adult Patients with Previously Treated Disease is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Marginal Zone Lymphoma in Combination with Rituximab in Adult Patients with Previously Treated DiseaseMelasmaMelasma is a health condition that can affect people of various ages. Medicines such as Hydroquinone, Mometasone Furoate, Tretinoin and related treatments are commonly included in care plans to address the underlying causes or provide symptomatic improvement.2 medicinesView MelasmaMeniere's DiseaseMeniere's Disease is a health condition that may require pharmaceutical intervention. Products containing Betahistine are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView Meniere's DiseaseMenopausal Vasomotor SymptomsMenopausal Vasomotor Symptoms describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Conjugated Estrogens, Estradiol, Tibolone and similar medicines, which work through different mechanisms to manage the condition or its effects.4 medicinesView Menopausal Vasomotor SymptomsMenorrhagiaMenorrhagia is a health condition that may require pharmaceutical intervention. Products containing Tranexamic Acid are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView MenorrhagiaMetastatic Breast CancerMetastatic Breast Cancer can affect wellbeing and daily functioning. The medicine types shown here, including Capecitabine, represent treatment options that may be considered for managing this condition effectively.1 medicineView Metastatic Breast CancerMigraineMigraine is a health condition that may require pharmaceutical intervention. Products containing Flurbiprofen are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView MigraineMigraine AttackMigraine Attack describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Rizatriptan, Zolmitriptan, Sumatriptan and similar medicines, which work through different mechanisms to manage the condition or its effects.3 medicinesView Migraine AttackMigraine Headache ProphylaxisMigraine Headache Prophylaxis describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Topiramate, Divalproex and similar medicines, which work through different mechanisms to manage the condition or its effects.2 medicinesView Migraine Headache ProphylaxisMigraine ProphylaxisMigraine Prophylaxis describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Propranolol, Flunarizine and similar medicines, which work through different mechanisms to manage the condition or its effects.2 medicinesView Migraine ProphylaxisMild Inflammatory Skin ConditionsMild Inflammatory Skin Conditions can affect wellbeing and daily functioning. The medicine types shown here, including Hydrocortisone, represent treatment options that may be considered for managing this condition effectively.1 medicineView Mild Inflammatory Skin ConditionsMild to Moderate Inflammatory DermatosesMild to Moderate Inflammatory Dermatoses can affect wellbeing and daily functioning. The medicine types shown here, including Desonide, represent treatment options that may be considered for managing this condition effectively.1 medicineView Mild to Moderate Inflammatory DermatosesMild to Moderate PainMild to Moderate Pain is a health condition that may require pharmaceutical intervention. Products containing Mefenamic Acid are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView Mild to Moderate PainMinor Skin IrritationsMinor Skin Irritations is a recognised medical concern that can interfere with daily activities. Among the treatments listed are Zinc Oxide, Benzalkonium Chloride and related products, which target specific aspects of the condition to improve outcomes.1 medicineView Minor Skin IrritationsMixed DyslipidaemiaMixed Dyslipidaemia can affect wellbeing and daily functioning. The medicine types shown here, including Bempedoic Acid, represent treatment options that may be considered for managing this condition effectively.3 medicinesView Mixed DyslipidaemiaModerate to Severe Atopic DermatitisModerate to Severe Atopic Dermatitis can affect wellbeing and daily functioning. The medicine types shown here, including Tacrolimus, represent treatment options that may be considered for managing this condition effectively.1 medicineView Moderate to Severe Atopic DermatitisModerate to Severe Dementia of The Alzheimer's TypeModerate to Severe Dementia of The Alzheimer's Type can affect wellbeing and daily functioning. The medicine types shown here, including Memantine, represent treatment options that may be considered for managing this condition effectively.1 medicineView Moderate to Severe Dementia of The Alzheimer's TypeModerately Severe Acute PainModerately Severe Acute Pain can affect wellbeing and daily functioning. The medicine types shown here, including Ketorolac, represent treatment options that may be considered for managing this condition effectively.1 medicineView Moderately Severe Acute PainMotion SicknessMotion Sickness is a health condition that may require pharmaceutical intervention. Products containing Promethazine are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.2 medicinesView Motion SicknessMultiple MyelomaPeople living with Multiple Myeloma face a complex health challenge. The treatments covered on this page represent medicine types that clinicians may consider as part of individualised management.3 medicinesView Multiple MyelomaMultiple Myeloma as Combination Therapy with Bortezomib and Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Combination Therapy with Bortezomib and Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for Transplant is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma as Combination Therapy with Bortezomib and Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Combination Therapy with Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Combination Therapy with Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for Transplant is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma as Combination Therapy with Dexamethasone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Combination Therapy with Melphalan and Prednisone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Combination Therapy with Melphalan and Prednisone for Patients with Previously Untreated Disease Who Are Not Eligible for Transplant is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma as Combination Therapy with Melphalan and Prednisone for Patients with Previously Untreated Disease Who Are Not Eligible for TransplantMultiple Myeloma as Monotherapy for Maintenance Treatment After Autologous Stem Cell TransplantationMultiple Myeloma as Monotherapy for Maintenance Treatment After Autologous Stem Cell Transplantation is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma as Monotherapy for Maintenance Treatment After Autologous Stem Cell TransplantationMultiple Myeloma as Monotherapy for Treatment After At Least One Prior TherapyMultiple Myeloma as Monotherapy for Treatment After At Least One Prior Therapy can affect wellbeing and daily functioning. The medicine types shown here, including Lenalidomide, represent treatment options that may be considered for managing this condition effectively.1 medicineView Multiple Myeloma as Monotherapy for Treatment After At Least One Prior TherapyMultiple Myeloma in Combination with Bortezomib and Dexamethasone in Adult Patients Who Have Received At Least One Prior Treatment Regimen Including LenalidomideMultiple Myeloma in Combination with Bortezomib and Dexamethasone in Adult Patients Who Have Received At Least One Prior Treatment Regimen Including Lenalidomide is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma in Combination with Bortezomib and Dexamethasone in Adult Patients Who Have Received At Least One Prior Treatment Regimen Including LenalidomideMultiple Myeloma in Combination with Daratumumab and Dexamethasone in Adult Patients Who Have Received At Least One Prior TherapyMultiple Myeloma in Combination with Daratumumab and Dexamethasone in Adult Patients Who Have Received At Least One Prior Therapy is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma in Combination with Daratumumab and Dexamethasone in Adult Patients Who Have Received At Least One Prior TherapyMultiple Myeloma in Combination with Dexamethasone in Adult Patients with Relapsed and Refractory Disease Who Have Received At Least Two Prior Treatment Regimens Including Both Lenalidomide and Bortezomib and Have Demonstrated Disease Progression on The Last TherapyMultiple Myeloma in Combination with Dexamethasone in Adult Patients with Relapsed and Refractory Disease Who Have Received At Least Two Prior Treatment Regimens Including Both Lenalidomide and Bortezomib and Have Demonstrated Disease Progression on The Last Therapy is an indication for treatment. See catalogue below.1 medicineView Multiple Myeloma in Combination with Dexamethasone in Adult Patients with Relapsed and Refractory Disease Who Have Received At Least Two Prior Treatment Regimens Including Both Lenalidomide and Bortezomib and Have Demonstrated Disease Progression on The Last TherapyMultiple Myeloma in Combination with Isatuximab and Dexamethasone in Adult Patients Who Have Received At Least Two Prior Therapies Including Lenalidomide and A Proteasome InhibitorMultiple Myeloma in Combination with Isatuximab and Dexamethasone in Adult Patients Who Have Received At Least Two Prior Therapies Including Lenalidomide and A Proteasome Inhibitor is a clinical indication. The medicines listed below cover treatment groups that may form part of a care plan.1 medicineView Multiple Myeloma in Combination with Isatuximab and Dexamethasone in Adult Patients Who Have Received At Least Two Prior Therapies Including Lenalidomide and A Proteasome InhibitorMultiple Sclerosis-associated FatigueMultiple Sclerosis-associated Fatigue can affect wellbeing and daily functioning. The medicine types shown here, including Naltrexone, represent treatment options that may be considered for managing this condition effectively.1 medicineView Multiple Sclerosis-associated FatigueMuscle SpasmsMuscle Spasms is a health condition that can affect people of various ages. Medicines such as Baclofen, Cyclobenzaprine, Methocarbamol and related treatments are commonly included in care plans to address the underlying causes or provide symptomatic improvement.6 medicinesView Muscle SpasmsMusculoskeletal DisordersMusculoskeletal Disorders is a health condition that may require pharmaceutical intervention. Products containing Flurbiprofen are among the treatments listed, offering a targeted approach to managing symptoms or addressing the underlying issue.1 medicineView Musculoskeletal DisordersMyasthenia GravisMyasthenia Gravis can affect wellbeing and daily functioning. The medicine types shown here, including Pyridostigmine, represent treatment options that may be considered for managing this condition effectively.1 medicineView Myasthenia GravisMydriasisMydriasis describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Cyclopentolate, Tropicamide and similar medicines, which work through different mechanisms to manage the condition or its effects.2 medicinesView MydriasisMyocardial Infarction PreventionMyocardial Infarction Prevention describes a set of symptoms or findings that can impact wellbeing. Treatment options often include Clopidogrel, Ticagrelor and similar medicines, which work through different mechanisms to manage the condition or its effects.2 medicinesView Myocardial Infarction PreventionMyoclonic SeizuresMyoclonic Seizures can affect wellbeing and daily functioning. The medicine types shown here, including Levetiracetam, represent treatment options that may be considered for managing this condition effectively.1 medicineView Myoclonic SeizuresMyoclonusMyoclonus can affect wellbeing and daily functioning. The medicine types shown here, including Piracetam, represent treatment options that may be considered for managing this condition effectively.2 medicinesView MyoclonusMyxoedema ComaMyxoedema Coma can affect wellbeing and daily functioning. The medicine types shown here, including Liothyronine, represent treatment options that may be considered for managing this condition effectively.1 medicineView Myxoedema Coma